Buscar
-
Pharmacovigilance - The next chapter
(Thérapie. vol. 74, n° 6, pp. 557-567, 2019-12)Article de revue -
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation
(British Journal of Clinical Pharmacology. vol. 85, n° 2, pp. 432-441, 2019)Article de revue -
Demandes d'études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données
(Thérapie. vol. 73, n° 1, pp. 1-12, 2018-02)Article de revue -
A review of Algerian medicinal plants used in the treatment of diabetes
(Journal of Ethnopharmacology. vol. 238, pp. 111841, 2019-06-28)Article de revue -
No arguments for extra risk from ibuprofen in SARS-COV2 infection
(Thérapie. vol. 75, n° 5, pp. 513-514, 2020)Article de revue -
Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study
(Pharmacoepidemiology and drug safety. vol. 27, n° 11, pp. 1174-1181, 2018-11)Article de revue -
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
(Clinical Colorectal Cancer. vol. 17, n° 2, pp. 129-139, 2018-06)Article de revue -
Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics
(Postgraduate medicine. vol. 130, n° 2, pp. 188-199, 2018-03)Article de revue -
Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database
(Pharmacoepidemiology and Drug Safety. vol. 28, n° 2, pp. 194-200, 2019)Article de revue -
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
(Pharmacoepidemiology and Drug Safety. vol. 29, n° 8, pp. 825-831, 2020)Article de revue